Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolates causative of invasive diseases in Mexican children

Journal of Infection in Developing Countries

Volumn 5, Issue 2, 2011, Pages 119-122

  Arredondo García, José Luis ^a   Calderón, Ernesto ^b   Echániz Aviles, Gabriela ^c   Soto Noguerón, Araceli ^c   Arzate, Patricia ^a   Amábile Cuevas, Carlos F ^d  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d Fundacion LUSARA   (Mexico)

Author keywords

Antibiotic resistance; Pediatric invasive disease; Serotypes; Streptoccocus penumoniae

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; LINCOSAMIDE; PENICILLIN G; STREPTOGRAMIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; LETHALITY; MAJOR CLINICAL STUDY; MALE; MEXICO; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 79952292870     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1348     Document Type: Article

References (16)

1. Austrian R (2004) Streptococcus pneumoniae. In Gorbach SL, Bartlett JG and Blacklow NR, editors. Infectious diseases, 3rd edition. Philadelphia: Lippincott Williams & Wilkins. 1605-1609.
2. Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S and Klein NP (2007) Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 26: 771-777.
3. CLSI (2007) Performance standards for antimicrobial susceptibility testing, seventeenth informational supplement, document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Weinstein MP, Klugman KP and Jones RN (2009) Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis 48: 1596-1600.
5. Žemliková H, Crisóstomo MI, Brandileone MC, Camou T, Castañeda E, Corso A, Echániz-Aviles G, Pástor M and Tomasz A (2005) Serotypes and clonal types of penicillin-susceptible Streptococcus pneumoniae causing invasive disease in children in five Latin American countries. Microbial Drug Resist 11: 195-204.
6. Ruvinsky R (2006) Resistencia a los antibióticos de los principales patógenos respiratorios. In Levy-Hara G and Sosa A, editors. Uso y abuso de los antibióticos ¿dónde estamos y adónde queremos llegar? Montevideo: Arena. 53-69.
7. Amábile-Cuevas CF (2010) Antibiotic resistance in Mexico: a brief overview of the current status and its causes. J Infect Dev Ctries 4: 126-131.
8. Amábile-Cuevas CF, Cabrera R, Fuchs LY and Valenzuela F (1998) Antibiotic resistance and prescription practices in developing countries. Meth Microbiol 27: 587-594.
9. Cardoso MRA, Nascimento-Carvalho CM, Ferrero F, Berezin EN, Ruvinsky R, Camargos PAM, Sant'Anna CC, Brandileone MCC, March MFP, Feris-Iglesias J, Maggi RS, Benguigui Y and Group C (2008) Penicillin-resistant pneumococcus and risk of treatment failure in pneumoniae. Arch Dis Child 93: 221-225.
10. Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R and Gudiol F (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333: 474-480.
11. Moritz EM and Hergenrother PJ (2007) The prevalence of plasmids and other mobile genetic elements in clinically important drug-resistance bacteria. In Amábile-Cuevas CF, editors. Antimicrobial resistance in bacteria. Wymondham: Horizon Bioscience 25-53.
12. Anzueto A and Norris S (2004) Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance. Int. J. Antimicrob Agents 24: 1-17.
13. Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F and Gilbert GL (2010) Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother 54: 1152-1159.
14. Echániz-Aviles G, Velázquez-Meza ME, Carnalla-Barajas MN, Soto-Noguerón A, Di Fabio JL, Solórzano-Santos F, Jiménez-Tapia Y and Tomasz A (1998) Predominance of the multiresistant 23F international clone of Streptococcus pneumoniae among isolates from Mexico. Microbial Drug Resist 4: 241-246.
15. Black S (2008) Changing epidemiology of invasive pneumococcal disease: a complicated story. Clin Infect Dis 47: 485-486.
16. Critchley IA, Jacobs MR, Brown SD, Traczewski MM, Tillotson GS and Janjic N (2008) Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem. Antimicrob. Agents Chemother 52: 2639-2643